The president has signed an executive order to protect the domestic production of glyphosate-based herbicides, such as Roundup, and elemental phosphorus, citing national security concerns related to food supply. This order also aims to provide immunity for manufacturers from liability, a move strongly criticized by health and environmental advocates who highlight the herbicide’s links to cancer and ongoing litigation against companies like Bayer. Critics argue this order prioritizes chemical companies over public health and betrays promises made to voters concerned about pesticide use.
Read More
The Supreme Court has agreed to hear Bayer’s appeal to block numerous state lawsuits concerning its Roundup weedkiller, specifically regarding failure to warn of potential cancer risks. The central issue is whether the Environmental Protection Agency’s approval of Roundup, without a cancer warning, preempts state court claims. Bayer, facing approximately 181,000 claims, argues for protection due to its compliance with federal regulations. The case stems from a Missouri jury’s award of $1.25 million to a man with non-Hodgkin’s lymphoma, and a previous Supreme Court decision declined a similar California case.
Read More
Georgia has enacted legislation shielding pesticide manufacturers, like Bayer, from lawsuits alleging failure to warn of potential dangers, mirroring a similar law in North Dakota. This law protects manufacturers adhering to federal labeling requirements, specifically impacting lawsuits against Bayer’s Roundup weed killer, which contains glyphosate. While the EPA considers glyphosate non-carcinogenic when used as directed, the law will not affect pre-existing litigation. Bayer, facing numerous lawsuits and significant financial settlements, actively supports such legislation alongside an extensive public relations campaign.
Read More
Bayer, a multinational pharmaceutical and life sciences company, has been ordered to pay a staggering $2.25 billion in damages after a jury linked their herbicide, Roundup, to cancer. As someone with a background in chemical engineering and scientific knowledge, I have some personal insights and opinions on this controversial issue.
Firstly, it is disheartening to see corporations like Bayer create subsidiaries to avoid paying the debts they owe. Johnson and Johnson’s bankruptcy maneuver serves as a reminder of the questionable practices that these companies resort to in order to evade their responsibilities. It is frustrating to witness the power that these corporations wield, seemingly above the law.… Continue reading
John Q. Hosedrinker